Sean Christensen, MD, PhD, FAAD
SESSIONS
F088 Skin Disease in Transplant Recipients and Immunosuppressed Patients
Mar 30, 2026
•
1:00 PM - 3:00 PM
•
Mile High 3A
DISCLOSURES
Castle Biosciences – Advisory Board(Honoraria); inhibitor therapeutics – Advisory Board(No Compensation Received); Sol-Gel Technologies – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria);